Company Filing History:
2 out of 1,832 
1 out of 10,754 
Years Active: 2003-2010
Title: Robert J H Scheffer: Innovator in Oxazole Production
Introduction
Robert J H Scheffer is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of chemistry, particularly in the production of oxazoles. With a total of 3 patents, his work has implications in the pharmaceutical industry.
Latest Patents
Scheffer's latest patents include innovative methods for the production of oxazoles. One of his patents describes a method for the production of oxazoles by condensing aromatic aldehydes with α-ketoximes to N-oxides and then reacting the same with activated acid derivatives. This invention relates to a process for preparing compounds of a specific formula through the conversion of aromatic aldehydes using α-ketoximes via N-oxides to halomethyloxazoles. Another patent focuses on improved methods for preparing oxazoles, resulting in higher yields with fewer impurities and contaminants. Oxazoles are valuable intermediates in synthesizing pharmaceutically active substances, such as peroxisome proliferator-activated receptor (PPAR) agonists, which can positively influence lipid and glucose metabolism.
Career Highlights
Throughout his career, Scheffer has worked with prominent companies in the pharmaceutical and chemical industries. Notable employers include Sanofi-Aventis Deutschland GmbH and BASF Aktiengesellschaft. His experience in these organizations has contributed to his expertise in chemical processes and innovation.
Collaborations
Scheffer has collaborated with esteemed colleagues, including Wolfgang Holla and Rolf-Ludwig Hoerlein. These partnerships have likely enhanced his research and development efforts in the field of oxazole production.
Conclusion
Robert J H Scheffer's contributions to the field of chemistry, particularly in the production of oxazoles, highlight his innovative spirit and dedication to advancing pharmaceutical science. His patents and collaborations reflect a commitment to improving methods that can lead to significant advancements in drug development.